Lincoln Pharma Share Price

Lincoln Pharma Share Price

NSE: LINCOLN
|
Pharmaceuticals

₹ 548.70

+₹5.20 (0.96%)
1D
Last updated 13 Oct, 2026, 15:52 IST

Lincoln Pharma Share Price Today

As of 14 Oct 2026, Lincoln Pharma share price is ₹548.70. The stock opened at ₹545.00, compared to its previous close of ₹543.50. During today's trading session, Lincoln Pharma share price moved in the range of ₹538.05 to ₹551.70, with an average price of ₹544.88 for the day. Looking at its last 52-week, the stock has touched a low of ₹440.00 and a high of ₹770.00. On the performance front, Lincoln Pharma share price has declined by 4.63% over the last six months and is up 4.65% on a year-on-year basis.

₹538.05
0.96% up today
₹551.70
1D LOW
1D HIGH

Lincoln Pharma Returns Calculator

Volume
16,873
Average traded price
₹543.99
Last traded time
03:52:29 13 Oct
Last traded quantity
1
Circuit
L
H
₹434.80
₹652.20
52-week
L
H
₹440.00
₹770.00
Mkt Cap Cr
1,090.12
P/E
11.3
P/B
1.44
ROA
10.83%
ROE
11.6%
ROCE
15.18%
Quick Ratio
4.53
EV/EBITDA
7.58
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Lincoln Pharma. has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Lincoln Pharma. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Lincoln Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,77,251.4282.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Lincoln Pharma

Lincoln Pharma Share Price
ISIN
INE405C01035
Sector Market Cap
₹ 1,090.12 Cr

Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.

Lincoln Pharma Financial Highlights

  • Revenue: Lincoln Pharma reported revenue of ₹704.48 crore in FY26 vs ₹645.71 crore in FY25. It showed an increase of 9.10% on a yearly basis.
  • Operating Profit: Lincoln Pharma reported an operating profit of ₹115.63 crore in FY26 vs ₹109.19 crore in FY25. It showed an increase of 5.90% on a year-on-year basis.
  • Net Profit: Lincoln Pharma reported a net profit of ₹87.89 crore in FY26 vs ₹82.35 crore in FY25. It showed an increase of 6.73% on a yearly basis.

Lincoln Pharma Quarterly Result Highlights

  • Lincoln Pharma reported revenue of ₹201.54 crore in Jun 2026, compared with ₹183.08 crore in Mar 2026, representing an increase of 10.08% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported an operating profit of ₹47.55 crore in Jun 2026, compared with ₹16.70 crore in Mar 2026, representing an increase of 184.73% on a quarter-on-quarter (QoQ) basis.
  • Lincoln Pharma reported a profit of ₹36.23 crore in Jun 2026, compared with ₹11.63 crore in Mar 2026, reflecting an increase of 211.52% on a QoQ basis.
  • The earnings per share (EPS) of Lincoln Pharma stood at ₹43.88 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
49.78%
FII
4.60%
Other DII
0.27%
Retail and other
45.36%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20254.72%
Dec 20254.70%
Mar 20265.19%
Jun 20264.60%
1 day
+0.96%
1 week
-5.04%
1 month
-12.00%
1 year
+4.65%
3 years
+9.89%
5 years
+43.88%
Day
Open / Close
Change %
13 Oct 26
₹545.00 / ₹548.70
+0.96%
12 Oct 26
₹556.15 / ₹543.50
-2.65%
09 Oct 26
₹558.00 / ₹558.30
-0.61%
08 Oct 26
₹563.20 / ₹561.70
-0.38%
Show more

Lincoln Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹671.03₹623.23₹580.55₹510.31
Other Income₹33.45₹22.48₹34.42₹22.47
Total Revenue₹704.48₹645.71₹614.97₹532.78
Total Expenses₹588.86₹536.52₹492.73₹432.30
Profit Before Tax₹115.63₹109.19₹122.24₹100.48
Tax₹27.73₹26.84₹28.94₹27.58
Profit After Tax₹87.89₹82.35₹93.30₹72.90
EPS - Basic₹43.88₹41.11₹46.58₹36.40
EPS - Diluted₹43.88₹41.11₹46.58₹36.40

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹115.63₹109.19₹122.24₹100.48
Income before WC changes₹121.94₹110.15₹105.48₹100.25
Change in Assets₹7.08-₹12.20-₹37.43-₹13.13
Change in Liabilities₹2.47₹21.37₹21.32-₹18.25
Change in WC₹9.56₹9.17-₹16.12-₹31.37
Cash flow from Operations₹106.36₹93.02₹63.22₹39.26
Cash flow from Investing-₹98.41-₹78.95-₹57.34-₹36.64
Cash flow from Financing₹0.16-₹6.40-₹5.18-₹4.50
Total Cash Flow₹8.11₹7.67₹0.70-₹1.88
Cash (Start of the year)₹13.41₹5.75₹5.05₹6.93
Cash (End of the year)₹21.53₹13.41₹5.75₹5.05

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹307.35₹297.07₹253.55₹220.21
Current Assets₹583.06₹499.94₹446.74₹367.21
Total Assets₹890.40₹797.01₹700.29₹587.42
Current Liabilities₹111.04₹106.22₹92.28₹72.15
Net Current Asset₹472.01₹393.72₹354.46₹295.07
Non-Current Liabilities₹21.73₹19.12₹15.18₹12.80
Equity Capital₹757.63₹671.67₹592.84₹502.47
Total Equity & Liabilities₹890.40₹797.01₹700.29₹587.42

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹671.03₹623.23₹580.55₹510.31
Other Income₹33.45₹22.48₹34.42₹22.48
Total Revenue₹704.48₹645.71₹614.97₹532.79
Total Expenses₹588.86₹536.52₹492.73₹432.34
Profit Before Tax₹115.63₹109.19₹122.24₹100.46
Tax₹27.73₹26.84₹28.94₹27.56
Profit After Tax₹87.89₹82.35₹93.30₹72.90
EPS - Basic₹43.88₹41.11₹46.58₹36.40
EPS - Diluted₹43.88₹41.11₹46.58₹36.40

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹115.63₹109.19₹122.24₹100.46
Income before WC changes₹121.94₹110.15₹105.49₹100.17
Change in Assets₹7.08-₹12.20-₹37.43-₹13.26
Change in Liabilities₹2.47₹21.37₹21.32-₹18.15
Change in WC₹9.56₹9.17-₹16.12-₹31.40
Cash flow from Operations₹106.36₹93.02₹63.24₹39.16
Cash flow from Investing-₹98.40-₹78.95-₹57.34-₹36.64
Cash flow from Financing₹0.16-₹6.40-₹5.18-₹4.50
Total Cash Flow₹8.12₹7.67₹0.73-₹1.99
Cash (Start of the year)₹12.97₹5.31₹4.58₹6.57
Cash (End of the year)₹21.09₹12.97₹5.31₹4.58

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹307.40₹297.12₹262.56₹220.26
Current Assets₹582.87₹499.75₹437.59₹367.00
Total Assets₹890.26₹796.87₹700.15₹587.26
Current Liabilities₹110.90₹106.08₹92.14₹71.98
Net Current Asset₹471.96₹393.67₹345.45₹295.02
Non-Current Liabilities₹21.73₹19.12₹15.18₹12.80
Equity Capital₹757.63₹671.67₹592.84₹502.47
Total Equity & Liabilities₹890.26₹796.87₹700.15₹587.26
* All values are in INR Crore
Qty
Bid
1
548.7
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
3
Neutral
1
Bullish
4
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
28.06
Bearish
ATR (14)
18.62
Neutral
STOCH(9,6)
2.78
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
45.62
Bearish
UO(9)
28.54
Bullish
ROC(12)
-9.95
Bearish
WillR(14)
-97.86
Bullish
Period
Simple value
Exponential vaue
5D
561.03
558.53
10D
570.62
568.79
20D
585.68
581.75
50D
601.63
596.51
100D
613.63
600.33
Volume trend — traded volume by day
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Lincoln Pharma Share Price
Lincoln Pharma
Pharmaceuticals
Add Stock
Add Another

Lincoln Pharma Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.